Business
– – U.S. Food and Drug Administration (FDA) has approved Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) new dose of COPAXONE drug application (sNDA) for three-times-a-week 40mg/mL....
Hi, what are you looking for?
Jewish Business News
All posts tagged "Copaxone"
Court
– Teva expects the Supreme Court to hear the case in April, a month before the Copaxone patents expire. – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA;...
Court
– The companies have agreed to settle pending patent litigation involving Copaxone in the UK, Netherlands and France. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA;...
Business
– Soros has once again succeeded in raising a few eyebrows on the international market by increasing his holdings in under pressure pharmaceutical giants...
Court
– The court dismissed a motion to put a lower court ruling on hold while it decides Teva’s appeal against earlier invalidation of Copaxone’s...
Business
– Perrigo is acquiring Ireland’s Elan, a beneficiary of royalties from rival multiple sclerosis treatment, Tysabri. – – A safety warning by the US...
Financial Research
– JPMorgan has downgraded Teva to “Underweight”, just two months after downgrading it to “Neutral.” – JPMorgan has downgraded Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; TASE: TEVA) to...
Business
– Acting CEO Eyal Desheh / Getty – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) acting CEO Eyal Desheh today said that Copaxone continued to lead...
Business
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is Israel’s largest and most successful public company. As such what it does, and how it thinks, become...
Business
– Russia’s Federal Antimonopoly Service: Teva’s refusal to supply Copaxone is neither justified economically nor technologically. – Teva’s Copaxone – /By Shiri Habib-Valdhorn and...